#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Liz Barrett Email
CEO . UroGen Pharma
New York, NY
LocationPrimary Email
How to contact Liz Barrett
Join and see Liz's contact info for free!Current Roles
Employees:
207Revenue:
$33.5MAbout
UroGen Pharma Ltd. (Nasdaq:URGN) is a clinical-stage biopharmaceutical company developing advanced non-surgical treatments to address unmet needs in the field of urology, with a focus on uro-oncology. The Company has developed RTGel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. UroGen Pharma's sustained release technology is designed to enable longer exposure of the urinary tract tissue to medications, making local therapy a potentially more effective treatment option. UroGen Pharma's lead product candidates, MitoGel (mitomycin urothelial gel) and VesiGel (mitomycin intravesical gel), are designed to potentially remove tumors by non-surgical means and to treat several forms of non-muscle invasive urothelial cancer, including low-grade upper tract urothelial carcinoma and bladder cancer, respectively. UroGen Pharma is headquartered in Raanana, Israel with U.S. headquarters in New York.UroGen Pharma Address
400 Alexander Park DriveNew York, NY
United States